what dose of bpc 157 should i take BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157: Top Peptide for Injury
Description
Hypercobalaminaemia Is Associated with Hepatic and Neoplastic Disease in Cats: A Cross Sectional Study

Why Choose Injections Over Pills

The clinician can compare injured and uninjured structures on contralateral sides of the body, follow the path of long bodies like nerves, muscles, bones and fascia, and explore how movement in one area impacts structures further along the kinetic chain

doi: 10.1023/A:1018893220943